Taiwan FDA registration 73e8022b42f65b07f0a704d7e5e673cb
Changying Ashton virus immunoglobulin A serum reagent
TW: 常盈愛氏頓病毒免疫球蛋白A血清試劑
Taiwan·Risk Class 2·IBL INTERNATIONAL GMBH·Registered Jan 10, 2006 – Jan 10, 2016CancelledRegistration details
- Analysis ID
- 73e8022b42f65b07f0a704d7e5e673cb
- Customs Code
- DHA00601586002
Company information
- Manufacturer
- IBL INTERNATIONAL GMBH
- Manufacturer Country
- Germany
- Authorized Representative
- WOLCH ENTERPRISES INC.
Product details
- Intended Use
- Enzyme immunoassay was used to qualitatively and quantitatively detect EBV EA IgA antibodies in serum and blood.
- Product Type (Level 1)
- C Immunology and microbiology
- Product Type (Level 2)
- C.3235 EB病毒血清試劑
- Import Information
- import
Dates and status
- Registration Date
- Jan 10, 2006
- Expiry Date
- Jan 10, 2016
- Cancellation Date
- Apr 25, 2018
Cancellation information
- Status
- Logged out
- Reason
- 自行鍵入
About this record
Access comprehensive regulatory information for Changying Ashton virus immunoglobulin A serum reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 73e8022b42f65b07f0a704d7e5e673cb and manufactured by IBL INTERNATIONAL GMBH. The authorized representative in Taiwan is WOLCH ENTERPRISES INC..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices